Omlonti 0.002% (0.02 mg/mL) ophthalmic solution Images
Generic Name: omidenepag isopropyl
This medication has been identified as Omlonti 0.002% (0.02 mg/mL) ophthalmic solution. It is supplied by Santen Inc.
Omlonti is used in the treatment of Glaucoma, Open Angle; Glaucoma/Intraocular Hypertension and belongs to the drug class ophthalmic glaucoma agents. Omlonti 0.002% (0.02 mg/mL) ophthalmic solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Omlonti
- Generic Name
- omidenepag isopropyl
- Strength
- 0.002% (0.02 mg/mL) ophthalmic solution
- Availability
- Prescription only
- Drug Class
- Ophthalmic glaucoma agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Santen Inc.
- National Drug Code (NDC)
- 65086-0002
More about Omlonti (omidenepag isopropyl ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.